Targeted Delivery of Paclitaxel in Liver Cancer Using Hyaluronic Acid Functionalized Mesoporous Hollow Alumina Nanoparticles

<p>LSCM images of SMMC-7721 cell line treated with FITC-labeled HMHA (a) and FITC-labeled MHA (b) at 0.5 h, 1 h, and 1.5 h. MHA, mesoporous hollow alumina nanoparticles; HMHA, hyaluronic acid functionalized mesoporous hollow alumina nanoparticles.</p>

BioMed Research International

fig5

Figure 5

Figure 5: Targeted Delivery of Paclitaxel in Liver Cancer Using Hyaluronic Acid Functionalized Mesoporous Hollow Alumina Nanoparticles 